Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Lung Cell Mol Physiol ; 301(4): L568-74, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21743027

ABSTRACT

Previously we showed that cytokine-induced neutrophil chemoattractant (CINC), but not macrophage inflammatory protein-2 (MIP-2), is detected in plasma after intratracheal challenge with LPS or the particular chemokines. To further understand the differences between CINC and MIP-2 flux from the lung, we attempted to detect the two chemokines in isolated erythrocytes and leukocytes in rats after intratracheal LPS challenge. In response to intratracheal LPS, we found both CINC and MIP-2 in isolated erythrocytes and leukocytes, suggesting that MIP-2 produced in the LPS-challenged lung entered the circulation like CINC. To assess the relative flux of CINC and MIP-2 from the intra-alveolar compartment into the blood, experiments were performed in rats implanted with vascular catheters in which both chemokines were either injected intratracheally (5 µg) or infused intravenously (20 ng/min) and subsequently measured in plasma or with the cellular elements. Both chemokines appeared in the blood following intratracheal injection, with CINC detected in plasma and cells but MIP-2 only detected in the cellular fraction of blood. Infusion of both chemokines allowed detection of MIP-2 and CINC in plasma and with the cellular elements, which allowed us to calculate clearance for each chemokine and to assess CINC and MIP-2 rates of appearance (Ra) following intratracheal injection. On the basis of plasma and whole blood clearance, CINC Ra was more than sevenfold and fourfold higher, respectively, than MIP-2 Ra. This analysis indicates that differences exist in the rate of flux of CINC and MIP-2 across the epithelial/endothelial barrier of the lung, despite similar molecular size.


Subject(s)
Catheterization/methods , Chemokine CXCL1 , Chemokine CXCL2 , Lung/drug effects , Trachea/drug effects , Animals , Chemokine CXCL1/blood , Chemokine CXCL1/pharmacokinetics , Chemokine CXCL2/blood , Chemokine CXCL2/pharmacokinetics , Enzyme-Linked Immunosorbent Assay , Erythrocytes/chemistry , Infusions, Intravenous , Leukocytes/chemistry , Lipopolysaccharides/adverse effects , Lipopolysaccharides/pharmacology , Lung/metabolism , Male , Rats , Rats, Sprague-Dawley , Trachea/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...